PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.\', \'McGill International TB Centre, McGill University, Montreal, Quebec, Canada.\', \'Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.\', \'Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.\', \'Division of Infectious Diseases, Department of Medicine, Washington University in St. Louis, Saint Louis, Missouri, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pmed.1003682
?:doi
?:hasPublicationType
?:journal
  • PLoS medicine
is ?:pmid of
?:pmid
?:pmid
  • 34197449
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.914
?:rankingScore_hIndex
  • 184
is ?:relation_isRelatedTo_publication of
?:title
  • Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all